These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
23. Effect of metoprolol versus carvedilol on outcomes in MADIT-CRT (multicenter automatic defibrillator implantation trial with cardiac resynchronization therapy). Ruwald MH; Ruwald AC; Jons C; Alexis J; McNitt S; Zareba W; Moss AJ J Am Coll Cardiol; 2013 Apr; 61(14):1518-26. PubMed ID: 23500269 [TBL] [Abstract][Full Text] [Related]
24. Prognostic significance of serum total cholesterol and triglyceride levels in patients hospitalized for heart failure with reduced ejection fraction (from the EVEREST Trial). Greene SJ; Vaduganathan M; Lupi L; Ambrosy AP; Mentz RJ; Konstam MA; Nodari S; Subacius HP; Fonarow GC; Bonow RO; Gheorghiade M; Am J Cardiol; 2013 Feb; 111(4):574-81. PubMed ID: 23206923 [TBL] [Abstract][Full Text] [Related]
25. Body mass index and prognosis in patients with chronic heart failure: insights from the Candesartan in Heart failure: Assessment of Reduction in Mortality and morbidity (CHARM) program. Kenchaiah S; Pocock SJ; Wang D; Finn PV; Zornoff LA; Skali H; Pfeffer MA; Yusuf S; Swedberg K; Michelson EL; Granger CB; McMurray JJ; Solomon SD; Circulation; 2007 Aug; 116(6):627-36. PubMed ID: 17638930 [TBL] [Abstract][Full Text] [Related]
26. Physician-directed patient self-management of left atrial pressure in advanced chronic heart failure. Ritzema J; Troughton R; Melton I; Crozier I; Doughty R; Krum H; Walton A; Adamson P; Kar S; Shah PK; Richards M; Eigler NL; Whiting JS; Haas GJ; Heywood JT; Frampton CM; Abraham WT; Circulation; 2010 Mar; 121(9):1086-95. PubMed ID: 20176990 [TBL] [Abstract][Full Text] [Related]
27. Incremental prognostic significance of peripheral endothelial dysfunction in patients with heart failure with normal left ventricular ejection fraction. Akiyama E; Sugiyama S; Matsuzawa Y; Konishi M; Suzuki H; Nozaki T; Ohba K; Matsubara J; Maeda H; Horibata Y; Sakamoto K; Sugamura K; Yamamuro M; Sumida H; Kaikita K; Iwashita S; Matsui K; Kimura K; Umemura S; Ogawa H J Am Coll Cardiol; 2012 Oct; 60(18):1778-86. PubMed ID: 23040568 [TBL] [Abstract][Full Text] [Related]
28. Relationship of depression to death or hospitalization in patients with heart failure. Sherwood A; Blumenthal JA; Trivedi R; Johnson KS; O'Connor CM; Adams KF; Dupree CS; Waugh RA; Bensimhon DR; Gaulden L; Christenson RH; Koch GG; Hinderliter AL Arch Intern Med; 2007 Feb; 167(4):367-73. PubMed ID: 17325298 [TBL] [Abstract][Full Text] [Related]
29. Changes in Dyspnea Status During Hospitalization and Postdischarge Health-Related Quality of Life in Patients Hospitalized for Heart Failure: Findings From the EVEREST Trial. Ambrosy AP; Khan H; Udelson JE; Mentz RJ; Chioncel O; Greene SJ; Vaduganathan M; Subacuis HP; Konstam MA; Swedberg K; Zannad F; Maggioni AP; Gheorghiade M; Butler J Circ Heart Fail; 2016 May; 9(5):. PubMed ID: 27140204 [TBL] [Abstract][Full Text] [Related]
30. Prognostic value of cystatin C on admission in heart failure with preserved ejection fraction. Carrasco-Sánchez FJ; Galisteo-Almeda L; Páez-Rubio I; Martínez-Marcos FJ; Camacho-Vázquez C; Ruiz-Frutos C; Pujol-De La Llave E J Card Fail; 2011 Jan; 17(1):31-8. PubMed ID: 21187262 [TBL] [Abstract][Full Text] [Related]
31. Basal functional status predicts three-month mortality after a heart failure hospitalization in elderly patients - the prospective RICA study. Formiga F; Chivite D; Conde A; Ruiz-Laiglesia F; Franco AG; Bocanegra CP; Manzano L; Pérez-Barquero MM; Int J Cardiol; 2014 Mar; 172(1):127-31. PubMed ID: 24452223 [TBL] [Abstract][Full Text] [Related]
32. Left Ventricular Reverse Remodeling With Biventricular Versus Right Ventricular Pacing in Patients With Atrioventricular Block and Heart Failure in the BLOCK HF Trial. St John Sutton M; Plappert T; Adamson PB; Li P; Christman SA; Chung ES; Curtis AB Circ Heart Fail; 2015 May; 8(3):510-8. PubMed ID: 25697851 [TBL] [Abstract][Full Text] [Related]
34. Failure of benefit and early hazard of bucindolol for Class IV heart failure. Anderson JL; Krause-Steinrauf H; Goldman S; Clemson BS; Domanski MJ; Hager WD; Murray DR; Mann DL; Massie BM; McNamara DM; Oren R; Rogers WJ; J Card Fail; 2003 Aug; 9(4):266-77. PubMed ID: 13680547 [TBL] [Abstract][Full Text] [Related]
35. Relationship between osteoprotegerin and mortality in decompensated heart failure with preserved ejection fraction. Aramburu-Bodas Ó; García-Casado B; Salamanca-Bautista P; Guisado-Espartero ME; Arias-Jiménez JL; Barco-Sánchez A; Santamaría-González JC; Formiga F; Montero-Pérez-Barquero M; Manzano L J Cardiovasc Med (Hagerstown); 2015 Jun; 16(6):438-43. PubMed ID: 25469731 [TBL] [Abstract][Full Text] [Related]
36. REPLACE DARE (Death After Replacement Evaluation) score: determinants of all-cause mortality after implantable device replacement or upgrade from the REPLACE registry. Chung MK; Holcomb RG; Mittal S; Steinberg JS; Gleva MJ; Mela T; Uslan DZ; Mitchell K; Poole JE; Circ Arrhythm Electrophysiol; 2014 Dec; 7(6):1048-56. PubMed ID: 25221331 [TBL] [Abstract][Full Text] [Related]
37. Clinical profile and prognostic value of low systolic blood pressure in patients hospitalized for heart failure with reduced ejection fraction: insights from the Efficacy of Vasopressin Antagonism in Heart Failure: Outcome Study with Tolvaptan (EVEREST) trial. Ambrosy AP; Vaduganathan M; Mentz RJ; Greene SJ; Subačius H; Konstam MA; Maggioni AP; Swedberg K; Gheorghiade M Am Heart J; 2013 Feb; 165(2):216-25. PubMed ID: 23351825 [TBL] [Abstract][Full Text] [Related]